|
adrenergic antagonist
An agent that binds to but does not activate adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists.
|
|
|
adrenergic antagonist
An agent that binds to but does not activate adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists.
anti-arrhythmia drug
A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres.
antihypertensive agent
Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.
|
|
|
N-(2-bromobenzyl)-N,N-dimethylethanaminium
|
|
(2-bromobenzyl)ethyldimethylaminium
|
ChEBI
|
|
2-bromo-N-ethyl-N,N-dimethylbenzenemethanaminium
|
ChEBI
|
|
N-ethyl-N,N-dimethyl-2-bromobenzenemethanaminium
|
ChEBI
|
|
4135284
|
Beilstein Registry Number
|
Beilstein
|
|
59-41-6
|
CAS Registry Number
|
ChemIDplus
|
